Novo Nordisc R7 - Search News

News

Novo Nordisk offers Wegovy for $199

Novo Nordisk promotes Wegovy for new customers as compounding ban takes effect

Novo Nordisk (NVO) stock in focus as the company promotes FDA-approved Wegovy as a ban for makers of compounding versions take effect. Read more here.

· 2d · on MSN

· 2d

Novo Nordisk offers Wegovy for $199 for first month to new cash-paying customers

· 2d

Novo Nordisk battles Wegovy copycats through discounted prices, legal threats

Yahoo Finance10d

Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill

Pharmaceutical giant Novo Nordisk (NVO) inks a $2.2 billion deal with biotech company Septerna (SEPN) to develop a GLP-1 weight-loss drug in the form of an oral pill. Septerna's stock is ...

U.S. News & World Report10d

Novo Nordisk Strikes $2.2 Billion Deal With Septerna to Develop New Obesity Treatments

COPENHAGEN (Reuters) -Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule medicines for obesity, type 2 diabetes and other cardio ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Novo Nordisk offers Wegovy for $199

Trending now